Vitravir 400 mg, 50 mg Tablet
PDF Leaflet Revision Date: 20 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in antiretroviral treatment experienced adult patients.
Dosage (summary)
Two tablets once daily with food.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- CYP3A inhibitors
- Rifampicin
- St. John's Wort
- Antidysrhythmics
- Anticonvulsants
Contraindications
- Hypersensitivity to darunavir or ritonavir
- Severe hepatic impairment
Common side effects
- Rash
- Diarrhea
- Nausea
- Fatigue
- Hyperglycemia
Counselling Points
- Take with food
- Monitor for skin reactions
- Regular liver function tests
- Avoid certain medications
Serious warnings
- Severe skin reactions
- Hepatotoxicity
- Pancreatitis
- Immune reconstitution syndrome
Important Disclaimer
The Vitravir 400 mg, 50 mg Tablet professional information leaflet below is the property of Mylan and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
